MedTrace Logo

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

NCT07082933 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-07-24

No results posted yet for this study

Summary

This is a multicenter retrospective cohort study on pulmonary arterial hypertension. It is expected to collect data from no less than 5,000 patients to compare the long-term overall survival of patients with and without diabetes, and analysis the risk factors of the overall survival .

Conditions

  • Pulmonary Arterial Hypertension (PAH)

Interventions

OTHER

Standard medical treatment

Standard medical treatment

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Yue Zhang, Doctor · Department of Health Management, Xijing Hospital, Air Force Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2027-08-01
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07082933 on ClinicalTrials.gov